Ninety-two percent of doctors state that PA process delays access to care; burden up over past five years
MONDAY, March 19, 2018 (HealthDay News) — The burdens associated with prior authorization (PA) are high and include a negative impact on clinical outcomes, reported by 92 percent of physicians, according to the results of a survey conducted for the American Medical Association (AMA).
The survey examined the experiences of 1,000 practicing physician (40 percent primary care physicians/60 percent specialists) with PA. Twenty-seven questions were administered in December 2017 in the web-based survey.
According to the results of the survey, 64 percent of respondents reported waiting at least one business day for a PA decision from health plans, with 30 percent waiting at least three business days. The PA process delayed care in 92 percent of cases; 78 percent of respondents reported that PA can at least sometimes lead to treatment being abandoned. Overall, 92 percent of respondents reported that PA can have a negative impact on patient clinical outcomes, with a significant negative impact reported by 61 percent. Eighty-four percent of physicians describe the burden associated with PA as high or extremely high for the physicians and staff in practice. Eighty-six percent reported an increase in PA burdens over the past five years.
“The AMA survey illustrates a critical need to help patients have access to safe, timely, and affordable care, while reducing administrative burdens that take resources away from patient care,” AMA chair-elect Jack Resneck Jr., M.D., said in a statement.
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing
Dense Breast Notification Linked to Increase in Use of Supplemental Ultrasound
Pediatricians Report Immigrant Families Avoiding Care for Their Children
2021 to 2025 Saw Reduction in Burnout Indicators Among Pediatricians
Physical Exams May Not Reliably Diagnose Pediatric Pneumonia
Barriers to Pediatric Cancer Clinical Trial Participation Identified
Guidance Provided for Transition From Pediatric to Adult Endocrine Care